SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-11-001351
Filing Date
2011-02-25
Accepted
2011-02-25 10:51:07
Documents
15
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2202198z10-k.htm 10-K 1490556
2 EX-21.1 a2202198zex-21_1.htm EX-21.1 3410
3 EX-23.1 a2202198zex-23_1.htm EX-23.1 3428
4 EX-31.1 a2202198zex-31_1.htm EX-31.1 7728
5 EX-31.2 a2202198zex-31_2.htm EX-31.2 7783
6 EX-32.1 a2202198zex-32_1.htm EX-32.1 4205
7 EX-32.2 a2202198zex-32_2.htm EX-32.2 4299
14 G201904.JPG g201904.jpg GRAPHIC 54076
15 G852033.JPG g852033.jpg GRAPHIC 5996
  Complete submission text file 0001047469-11-001351.txt   5125487

Data Files

Seq Description Document Type Size
8 EX-101.INS amag-20101231.xml EX-101.INS 667563
9 EX-101.SCH amag-20101231.xsd EX-101.SCH 24045
10 EX-101.CAL amag-20101231_cal.xml EX-101.CAL 51934
11 EX-101.LAB amag-20101231_lab.xml EX-101.LAB 274455
12 EX-101.PRE amag-20101231_pre.xml EX-101.PRE 137717
13 EX-101.DEF amag-20101231_def.xml EX-101.DEF 90571
Mailing Address 100 HAYDEN AVENUE LEXINGTON MA 02140
Business Address 100 HAYDEN AVENUE LEXINGTON MA 02140 6174972070
AMAG PHARMACEUTICALS INC. (Filer) CIK: 0000792977 (see all company filings)

IRS No.: 042742593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-10865 | Film No.: 11638924
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Assistant Director 1